<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00381277</url>
  </required_header>
  <id_info>
    <org_study_id>DG-1</org_study_id>
    <nct_id>NCT00381277</nct_id>
  </id_info>
  <brief_title>The Effects of Sports Drinks on Urinary Lithogenicity</brief_title>
  <official_title>The Effects of Sports Drinks on Urinary Lithogenicity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA New York Harbor Healthcare System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA New York Harbor Healthcare System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of sports drinks on the tendency to form kidney stones has not been assessed.
      Patients will drink 1 liter a day of 2 sports drinks and collect urine to determine changes
      in urine chemistry that may decrease the risk of forming stones.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will drink 1 liter of water each day for one week in the control period, then 1
      liter of sports drink each day for one week during the experimental period. Urine collections
      will be performed during both periods. Diet will be chosen by participants and a food diary
      will be kept so that participants can replicate diet during the urine collections.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">September 2006</completion_date>
  <primary_completion_date type="Actual">March 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Urinary supersaturation of calcium oxalate</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Urinary citrate excretion</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Urinary calcium excretion</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Urinary sodium excretion</measure>
  </primary_outcome>
  <enrollment>10</enrollment>
  <condition>Urolithiasis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gatorade</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Performance</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-80 years old

          -  men and women

          -  able to sign informed consent

        Exclusion Criteria:

          -  history of kidney stones

          -  bone disease

          -  parathyroid disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David S Goldfarb, MD</last_name>
    <role>Study Director</role>
    <affiliation>New York Harbor VAMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York Harbor VAMC</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2006</study_first_submitted>
  <study_first_submitted_qc>September 26, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2006</study_first_posted>
  <last_update_submitted>February 18, 2011</last_update_submitted>
  <last_update_submitted_qc>February 18, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2011</last_update_posted>
  <responsible_party>
    <name_title>David S Goldfarb MD</name_title>
    <organization>New York Harbor VA Medical Center</organization>
  </responsible_party>
  <keyword>nephrolithiasis</keyword>
  <keyword>citrate</keyword>
  <keyword>oxalate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urolithiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

